Ranitidine (Zantac): Uses, How It Works, and Safety
Quick summary Ranitidine was an H2-receptor blocker used for acid-related conditions such as duodenal ulcer, peptic ulcer, reflux symptoms, and Zollinger-Ellison syndrome. This page summarizes the original product information and key safety points to...
This content is for educational purposes only and does not replace medical advice, diagnosis or treatment from a qualified healthcare professional.
Quick summary
Ranitidine was an H2-receptor blocker used for acid-related conditions such as duodenal ulcer, peptic ulcer, reflux symptoms, and Zollinger-Ellison syndrome. This page summarizes the original product information and key safety points to check with an official leaflet or healthcare professional.
Medical disclaimer
This article is for general information only. It does not replace medical advice, diagnosis, or the official product leaflet. If you have symptoms, a medical condition, pregnancy, breastfeeding, kidney or liver disease, or take other medicines, confirm the correct guidance with a doctor or pharmacist.
What is ranitidine?
Ranitidine (also written as ranitidina) is a medicine that was used for acid-related stomach and esophageal conditions. The original content lists ranitidine hydrochloride and ranitidine bismuth citrate as product ingredients.
Brand names mentioned in the United States include Zantac, Zantac 150, Zantac 300, and Zantac 75.
How ranitidine worked
Ranitidine antagonized histamine H2 receptors in the stomach’s parietal cells. In practical terms, it reduced both stimulated and basal gastric acid secretion and also reduced pepsin production.
What ranitidine was used for
The original content lists the following uses:
- Duodenal ulcer
- Peptic ulcer
- Benign gastric ulcer
- Zollinger-Ellison syndrome
- Reflux esophagitis and related symptoms
- Prevention of recurrent bleeding in patients with bleeding ulcer
- Prevention of stress-ulcer bleeding in critically ill patients
- Prevention of acid aspiration syndrome before surgery in patients at risk, including obstetric patients during childbirth
- Short-term treatment of peptic ulcer and gastro-oesophageal reflux in children
Dosage information from the original content
The following information reflects the source text and should be verified against an official leaflet or clinician guidance before use.
| Group | Original content summary |
|---|---|
| Adults and teenagers over 12 years | The source lists oral and intravenous regimens for duodenal ulcer, gastric ulcer, Zollinger-Ellison syndrome, reflux esophagitis, stress-ulcer bleeding prevention, and prevention of Mendelson’s syndrome. |
| Children | The source lists weight-based oral dosing for peptic ulcer and gastroesophageal reflux, and intravenous dosing for children 6 months to 11 years. |
| Renal insufficiency | The source notes dose adjustment when creatinine clearance is below 50 mL/min. |
Important: The original content includes detailed dosing schedules, but exact dosing should always be checked in the official leaflet or by a clinician, especially for children, kidney disease, and intravenous use.
How it was taken
The original content states that ranitidine was taken orally, and tablets should be swallowed whole with water and not broken or crushed.
Contraindications listed in the source
- Hypersensitivity
- Acute porphyria
Warnings and precautions
The source highlights several situations where caution was needed:
- Kidney failure or reduced kidney function
- Need to rule out malignant lesions
- Older adults, especially with chronic lung disease, diabetes, or immunocompromise, may have increased risk of community-acquired pneumonia
- Children: the source advises checking whether use is appropriate, especially in newborns, where safety and efficacy were not established
- Intravenous use: administration speed should not be exceeded because of the risk of heart rhythm disturbance
Liver and kidney considerations
The original content advises caution in liver failure and notes that intravenous administration for more than 5 days may increase liver enzymes.
For kidney failure, the source recommends dose adjustment and gives a lower-dose approach when creatinine clearance is below 50 mL/min.
Drug interactions listed in the source
Ranitidine was reported to interact with several medicines and tests:
- May decrease absorption of ketoconazole, atazanavir, delavirdine, and gefitinib
- May increase absorption of triazolam, midazolam, and glipizide
- Antacids containing aluminum or magnesium hydroxides may reduce absorption if taken on an empty stomach; spacing was advised in the source
- Sucralfate at high doses may reduce absorption; the source advises spacing doses
- May modify prothrombin time with coumarin anticoagulants such as warfarin
- At high doses, may reduce excretion of procainamide and N-acetylprocainamide
- May interfere with gastric acid secretion tests and skin tests with allergen extracts
- May cause a false positive urine protein test with Multistix
Pregnancy and breastfeeding
The source says ranitidine crosses the placenta and should be used only if considered essential. It also advises avoiding use in the first trimester.
For breastfeeding, the source states that ranitidine is excreted in breast milk and recommends avoiding administration during lactation unless a doctor considers it essential.
Driving and using machines
No specific effect on driving ability was expected in the source content. However, if dizziness occurs, the advice is to avoid driving or using dangerous machinery.
Side effects listed in the source
The original content mentions the following infrequent adverse reactions:
- Abdominal pain
- Constipation
- Nausea
The source also notes that these symptoms usually improve with continued treatment, although the wording in the original text appears to contain an error.
Key takeaways
- Ranitidine was used for several acid-related conditions.
- It worked by reducing stomach acid production.
- Kidney function, pregnancy, breastfeeding, and drug interactions were important safety considerations.
- Exact dosing and suitability should be checked against the official leaflet or a healthcare professional.
Safety reminder
If you are reviewing ranitidine information for yourself or someone else, confirm the current guidance with a pharmacist, doctor, or official medicine leaflet before making any treatment decisions. Do not rely on this page alone for dosing or safety advice.
Frequently asked questions
▸ What was ranitidine used for?
The source lists duodenal ulcer, peptic ulcer, gastric ulcer, reflux esophagitis, Zollinger-Ellison syndrome, and prevention of certain bleeding-related complications.
▸ How did ranitidine work?
It blocked histamine H2 receptors in the stomach, which reduced gastric acid secretion and pepsin production.
▸ Was ranitidine used in children?
Yes. The source includes short-term treatment of peptic ulcer and gastro-oesophageal reflux in children, with age- and weight-based dosing.
▸ What safety issues were mentioned?
The source mentions kidney impairment, liver caution, pregnancy and breastfeeding considerations, interactions, and the need for careful intravenous administration.
▸ Should I use the dosing in this article as medical advice?
No. The dosing information is a summary of the original content and should be verified in the official leaflet or with a clinician before any use.
Sources and reference suggestions
The original content referenced FDA and U.S. National Library of Medicine resources. For verification, consult official medicine information and ingredient databases.
Medical disclaimer
This content is for educational purposes only. It should not be used as a substitute for professional medical advice, diagnosis or treatment. Always ask a doctor, pharmacist or qualified healthcare professional before starting, stopping or changing any medicine.
Sources and verification
The following sources or official references are listed to support verification of the medicine information discussed in this article.
Medicine information can change and may vary depending on country, product formulation, patient history and professional guidance. Always check official medicine information and ask a healthcare professional for personal medical questions.